Journal article
Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
- Abstract:
- AIMS/HYPOTHESIS: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. METHODS: We used the European EPIC-InterAct case-cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). RESULTS: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). CONCLUSIONS/INTERPRETATION: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 983.8KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00125-023-05948-x
Authors
+ Foundation for the National Institutes of Health
More from this funder
- Funder identifier:
- 10.13039/100000009
- Grant:
- DK-26190
+ Novo Nordisk Fonden
More from this funder
- Funder identifier:
- 10.13039/501100009708
- Grant:
- NNF19OC0057274
+ Instituto de Salud Carlos III
More from this funder
- Funder identifier:
- 10.13039/501100004587
- Grant:
- CPII20/00009
+ Diabetesförbundet
More from this funder
- Funder identifier:
- 10.13039/501100008546
- Grant:
- DIA2022-735
- Publisher:
- Springer
- Journal:
- Diabetologia More from this journal
- Volume:
- 66
- Issue:
- 8
- Pages:
- 1460-1471
- Publication date:
- 2023-06-10
- DOI:
- EISSN:
-
1432-0428
- ISSN:
-
0012-186X
- Language:
-
English
- Keywords:
- Pubs id:
-
1470806
- Local pid:
-
pubs:1470806
- Source identifiers:
-
W4380203301
- Deposit date:
-
2026-05-08
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record